Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Ringers Solution for Infusion

ATC code: 
B05BB01
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 05 Mar 2025

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PL 0116/0349.

Ringers Solution for Infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER

Ringer’s Solution for Infusion

Active substances: sodium chloride, potassium chloride and calcium chloride dihydrate

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.
  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet.

What is in this leaflet:

1. What Ringer’s Solution for Infusion is and what it is used for
2. What you need to know before you are given Ringer’s Solution for Infusion
3. How you will be given Ringer’s Solution for Infusion
4. Possible side effects
5. How to store Ringer’s Solution for Infusion
6. Contents of the pack and other information

1. What Ringer’s Solution for Infusion is and what it is used for

Ringer’s Solution for Infusion is a solution of the following substances in water:

  • sodium chloride
  • potassium chloride
  • calcium chloride dihydrate
  • Ringer’s Solution for Infusion is used to treat a loss of body water (dehydration) and chemicals (e.g. by heavy sweating, kidney disorders)

2. What you need to know before you are given Ringer’s Solution for Infusion
Do NOT receive Ringer’s Solution for Infusion if you are suffering from any of the following conditions
  • Preterm newborn infants and term newborn infants (≤28 days of age): Your child must not receive a certain antibiotic called ceftriaxone as a drip into a vein at the same time with this medicine
  • when there is too much fluid in the spaces around the cells of the body (extracellular hyperhydration)
  • when there is a larger volume of blood in the blood vessels than there should be (hypervolaemia)
  • severe kidney failure (when your kidneys do not work well and you require dialysis)
  • uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such as:
    • shortness of breath
    • swelling of the ankles
  • when there is too much fluid in the body caused by too many salts in the blood (hypertonic dehydration)
  • higher levels of potassium in the blood than normal (hyperkalaemia)
  • higher levels of sodium in the blood than normal (hypernatraemia)
  • higher levels of calcium in the blood than normal (hypercalcaemia)
  • higher levels of chloride in the blood than normal (hyperchloraemia)
  • severe high blood pressure (hypertension)
  • build up of fluid under the skin, affecting all parts of the body (general oedema)
  • liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis)
  • if you are taking cardiac glycosides (cardiotonics) used to treat heart failure, such as digitalis or digoxin. (see also “Other Medicines and Ringer’s Solution for Infusion”)

Warnings and precautions

Talk to your doctor or nurse if you have or have had any of the following medical conditions:

  • respiratory failure (lung disease) (special monitoring may be required in the above conditions)
  • any type of heart disease or impaired heart function
  • impaired kidney function
  • high blood pressure (hypertension)
  • build up of fluid under the skin, particularly around the ankles (peripheral oedema)
  • build up of fluid in the lungs (pulmonary oedema)
  • high blood pressure during pregnancy (pre-eclampsia)
  • a disease that causes high levels of a hormone called aldosterone (aldosteronism)
  • any other condition associated with sodium retention (when the body retains too much sodium), such as treatment with steroids (see also below “Other medicines and Ringer’s Solution for Infusion”).
  • if you have problems with the fluid levels in your brain (for example, because of meningitis, bleeding in the skull or brain injury)
  • if you have a condition that could cause high level of vasopressin, a hormone regulating fluid in your body, such as
    • a sudden and serious illness or injury
    • you have had surgery
    • brain disease
    • you are taking certain medicines

These conditions may increase the risk of low levels of sodium in your blood, which can lead to headache, nausea, seizures, lethargy, coma and swelling in the brain.

People who are at higher risk of brain swelling are:

  • children
  • women (particularyly if you are of a fertile age)

  • if you have a condition where the glands in the body are not making enough of some hormones (adrenocortical insufficiency)
  • a loss of water from the body (acute dehydration, e.g. from vomiting or diarrhoea)
  • extensive tissue damage (can occur in severe burns)
  • diseases associated with high levels of vitamin D (e.g. sarcoidosis, a disease affecting the skin and internal organs)
  • diseases associated with kidney stones
  • ceftriaxone, an antibiotic, must not be mixed with or given at the same time as any solutions with calcium in, when given to you through the vein. This medicine contains calcium. If you are older than 28 days, you may be given ceftriaxone and a solution with calcium, one after the other, as long as your doctor takes action to avoid medicines reacting with each other. If you or your child suffer from low blood volume your doctor will avoid giving you or your child calcium and ceftriaxone sequentially heart failure.

When you are given this infusion, your doctor will take blood and urine samples and monitor:

  • the amount of fluid in your body
  • your vital signs
  • the amount of chemicals such as sodium, potassium, calcium and chlorides in your blood (your plasma electrolytes)

Although Ringer’s Solution for Infusion contains potassium and calcium, it does not contain enough to:

  • maintain levels of these chemicals
  • treat very low blood plasma levels of potassium (severe potassium deficiency) or calcium (severe calcium deficiency).

Once your dehydration has been treated using Ringer’s Solution for Infusion, your doctor will give you a different infusion to provide you with enough potassium and calcium. Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by infusion into a vein). If you are given Ringer’s Solution for Infusion for a long time, you will be given an extra source of nutrients.

Calcium chloride can be harmful if injected into the body tissues. Therefore, the Ringer’s Solution for Infusion must not be given by injecting it into a muscle (intramuscular injection). Also, your doctor will make every effort to avoid the escape of the solution into the tissues surrounding the vein.

Ringer’s Solution for Infusion must not be given through the same needle as a blood transfusion. This can damage the red blood cells or cause them to clump together.

Other medicines and Ringer’s Solution for Infusion

Tell your doctor or nurse if you are taking or have recently taken any other medicines.

It is particularly important that you inform your doctor if you are taking:

  • ceftriaxone (an antibiotic), when given intravenously (see Warnings and precautions)
  • cardiac glycosides (cardiotonics) such as digitalis or digoxin, used to treat heart failure as they must not be used with Ringer’s Solution for Infusion (see also section “Do not receive Ringer’s Solution for Infusion if you are suffering from…”). The effects of these drugs can be increased by calcium. This can lead to life threatening changes to the heart rhythm

The following medicines can cause the body to store up sodium and water, leading to tissue swelling and high blood pressure:

  • corticosteroids (anti-inflammatory medicines)
  • carbenoxolone (an anti-inflammatory medicine used to treat stomach ulcers)

The following medicines can increase the concentration of potassium in the blood. This effect can be life-threatening. A rise in the blood potassium levels is more likely to occur if you have kidney disease.

  • potassium-sparing diuretics (certain water tablets, e.g. amiloride, spironolactone, triamterene)
    (Note that these medicines may be included in combination medicinal products)
  • angiotensin converting enzyme (ACE) inhibitors (used to treat high blood pressure)
  • angiotensin II receptor antagonists (used to treat high blood pressure)
  • tacrolimus (used to prevent rejection of a transplant and to treat some skin diseases)
  • cyclosporin (used to prevent rejection of a transplant)

Some medicines can increase the risk of side effects due to low levels of sodium in blood. These medicines may include:

  • water tablets (diuretics)
  • medicines for pain and /or inflammation (also known as NSAIDs)
  • antipsychotics
  • medicines used to treat depression (selective serotonin reuptake inhibitors)
  • medicines that produce morphine-like effects (opioids)
  • certain medicines used to treat epilepsy (antiepileptics)
  • hormone called oxytocin (causes uterus to contract)
  • certain medicines used to treat cancer (chemotherapy).
  • cholestrol medicine
  • anti-diabetic medicine

Other medicines that can affect or be affected by Ringer’s Solution for Infusion include:

  • thiazide diuretics such as hydrochlorothiazide or chlortalidone
  • vitamin D

Ringer’s Solution for Infusion with food and drink

You should ask your doctor about what you can eat or drink.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.

Ringer’s Solution for Infusion can be used safely during pregnancy or breast-feeding as long as the electrolyte and fluid balance is controlled and monitored by your doctor. Your doctor will take special caution if you are taking oxytocin during labour.

Calcium can reach your unborn baby through the placenta and, after birth, through the breast milk. Your doctor will monitor the levels of chemicals in your blood and the amount of fluid in your body.

However, if another medicine is to be added to your solution for infusion during pregnancy particularly during labour or breast-feeding you should:

  • consult your doctor
  • read the Package Leaflet of the medicine that is to be added.

Driving and using machines

Ringer’s Solution for Infusion does not affect your ability to drive or use machines.

3. How to use Ringer’s Solution for Infusion

Ringer’s Solution for Infusion will be given to you by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given.

This will depend on your age, weight, and condition and the reason for treatment. The amount you are given may also be affected by other treatments you are receiving.

You should NOT be given Ringer’s Solution for Infusion if there are particles floating in the solution or if the pack is damaged in any way.

Ringer’s Solution for Infusion will usually be given to you through a plastic tube attached to a needle in a vein. Usually a vein in your arm is used to give you the infusion. However, your doctor may use another method to give you the medicine.

When you are given Ringer’s Solution for Infusion, your doctor will perform blood tests to monitor your:

  • blood levels of sodium, potassium, calcium and chloride
  • your fluid levels

Any unused solution should be thrown away.

You should NOT be given an infusion of Ringer’s Solution for Infusion from a bag that has been partly used.

If you receive more Ringer’s Solution for Infusion than you should

If you are given too much Ringer’s Solution for Infusion (over-infusion), or you are given your infusion too quickly, this may lead to the following symptoms:

  • water and/or sodium (salt) overload with build up of liquid in the tissues (oedema) causing swelling
  • pins and needles in the arms and legs (paresthesia)
  • muscle weakness
  • an inability to move (paralysis)
  • an irregular heartbeat (cardiac arrhythmias)
  • heart block (a very slow heartbeat)
  • cardiac arrest (the heart stops beating; a life-threatening situation)
  • confusion
  • a decreased appetite (anorexia)
  • feeling sick (nausea)
  • vomiting
  • constipation
  • abdominal pain
  • mental disturbances such as irritability or depression
  • drinking lots of water (polydipsia)
  • producing more urine than normal (polyuria)
  • kidney disease due to build up of calcium in the kidneys (nephrocalcinosis)
  • kidney stones
  • coma (unconsciousness)
  • chalky taste
  • redness (hot flushes)
  • dilatation of the blood vessels in the skin (peripheral vasodilatation)
  • acidification of the blood (acidosis) leading to tiredness, confusion, lethargy and increased breathing rate

If you develop any of these symptoms you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment depending on the symptoms.

If a medicine has been added to your Ringer’s Solution for Infusion before over-infusion occurs, that medicine may also cause symptoms. You should read the Package Leaflet of the added medicine for a list of possible symptoms.

Stop receiving your Ringer’s Solution for Infusion

Your doctor will decide when to stop giving you this infusion.

If you have any further questions on the use of this medicine, ask your doctor or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The side effects are listed according to their frequencies.

Very common (occurring in more than 1 of every 10 patients)

  • changes in the concentrations of the chemicals in the blood (electrolyte disturbances)

If you suffer from heart disease or fluid in the lungs (pulmonary oedema):

  • too much fluid in the body (hyperhydration)
  • heart failure

Other
  • reactions due to the administration technique:
    • fever (febrile response)
    • infection at the site of infusion
    • local pain or reaction (redness or swelling at the site of infusion)
    • irritation and inflammation of the vein into which the solution is infused (phlebitis).
      This can cause redness, pain or burning and swelling along the path of the vein into which the solution is infused.
    • the formation of a blood clot (venous thrombosis) at the site of infusion, which causes pain, swelling or redness in the area of the clot
    • escape of the infusion solution into the tissues around the vein (extravasation). This can damage the tissues and cause scarring.
  • low levels of sodium in the blood (hyponatraemia)
  • swelling of the brain which may cause brain injury (cerebral-oedema)

If a medicine has been added to the solution for infusion, the added medicine may also cause side effects. These side effects will depend on the medicine that has been added. You should read the Package Leaflet of the added medicine for a list of possible symptoms.

If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom:

Via the Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard

Ireland:

HPRA Pharmacovigilance
Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971
Fax: +353 1 6762517
Website: www.hpra.ie

Malta:

ADR Reporting
Website: www.medicinesauthority.gov.mt/adrportal

5.How to store Ringer’s Solution for Infusion

Keep this medicine out of the sight and reach of children.

This medicinal product does not require any special temperature storage conditions

Do not use this medicine after the expiry date which is stated on the bag. The expiry date refers to the last day of that month.

Do not use this medicine if you notice particles floating in the solution or if the unit is damaged in any way.

6.Contents of the pack and other information
What Ringer’s Solution for Infusion contains

The active substances are:

  • sodium chloride: 8.60 g per litre
  • potassium chloride: 0.30 g per litre
  • calcium chloride dihydrate: 0.33 g per litre

The other ingredients are:

  • water for injections
  • sodium hydroxide

What Ringer’s Solution for Infusion looks like and contents of the pack

Ringer’s Solution for Infusion is a clear solution, free from visible particles.

It is supplied in a polyolefin/polyamide plastic bags (Viaflo). Each bag is wrapped in a sealed, protective, outer plastic overpouch.

The bag sizes are:

  • 500 ml
  • 1000 ml

The bags are supplied in cartons. Each carton contains one of the following quantities:

  • 1 bag of 500 ml
  • 1 bag of 1000 ml
  • 20 bags of 500 ml
  • 10 or 12 bags of 1000 ml
  • 10 bags of 1000 ml

Not all pack sizes may be marketed

Marketing Authorisation Holder and Manufacturers

Marketing Authorisation Holder:

United Kingdom:

Baxter Healthcare Ltd.
Caxton Way
Thetford
Norfolk
IP24 3SE
United Kingdom

Republic of Ireland and Malta:

Baxter Holding B.V.
Kobaltweg 49
3542CE Utrecht
Netherlands

Manufacturers for Great Britain:

Baxter S.A.
Boulevard René Branquart, 80
7860 Lessines
Belgium

Baxter Healthcare Ltd.
Caxton Way
Thetford
Norfolk
IP24 3SE
United Kingdom

Bieffe Medital S.A.
Ctra de Biescas-Senegüé
22666 Sabiñánigo (Huesca)
Spain

Manufacturers for Ireland and Malta:

Baxter S.A.
Boulevard René Branquart, 80
7860 Lessines
Belgium

Bieffe Medital S.A.
Ctra de Biescas-Senegüé
22666 Sabiñánigo (Huesca)
Spain

This leaflet was last revised in July 2023

For information about Ringer’s Solution for Infusion or to request this leaflet in formats such as audio or large print please contact the Marketing Authorisation Holder: Tel: +44 (0)1635 206345

Baxter and Viaflo are trademarks of Baxter International lnc.

TH-30-02-201

Baxter Healthcare Ltd
Company image
Address
Caxton Way, Thetford, Norfolk, IP24 3SE, UK
Fax
+44 (0)1635 206071
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0)1635 206345
Medical Information Fax
+44 (0)1635 206071